Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Stock Market Drop: 3 Cheap Healthcare Stocks to Buy Right Now
10:00am, Saturday, 18'th Jun 2022 The Motley Fool
Declines in the market make now the time to go bargain hunting.
FDA clears path for CDC to authorize mRNA vaccines in youngest children, but Florida officials say they do not recommend them
07:43pm, Friday, 17'th Jun 2022 MarketWatch
The Food and Drug Administration took the advice of a panel of advisers and authorized the COVID-19 vaccines developed by BioNTech and Pfizer and Moderna for children as young as six months old on Fr
Top Research Reports for Pfizer, Booking & Dominion Energy
04:59pm, Friday, 17'th Jun 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), Booking Holdings Inc. (BKNG), and Dominion Energy, Inc. (D).
Valneva (VALN) Stock Declines 59% in 3 Months: Here's Why
02:14pm, Friday, 17'th Jun 2022 Zacks Investment Research
Though Valneva's (VALN) COVID-19 vaccine looks promising, the European Commission's intent to terminate the advance purchase agreement for the vaccine puts the future of the company's COVID-19 vaccine
It's time to let pharmacists prescribe COVID-fighting pills like Paxlovid
01:54pm, Friday, 17'th Jun 2022 MarketWatch
Pfizer's Paxlovid and Merck's Lagevrio can prevent cases of COVID from turning truly serious.
Is Most-Watched Stock Pfizer Inc. (PFE) Worth Betting on Now?
01:00pm, Friday, 17'th Jun 2022 Zacks Investment Research
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
H Lundbeck AS (HLUYY) Surges 12.5%: Is This an Indication of Further Gains?
12:44pm, Friday, 17'th Jun 2022 Zacks Investment Research
H Lundbeck AS (HLUYY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price incre
Pharma Stock Roundup: FDA Panel Nod for PFE, MRNA Young Kids' COVID Jabs & More
12:37pm, Friday, 17'th Jun 2022 Zacks Investment Research
FDA panel recommends the use of PFE, MRNA COVID vaccine in kids under five. LLY's Alzheimer's candidate fails to show clinical benefit in study. FDA approves expanded use of LLY's Olumiant.
Oxford Industries and Flagstar Bancorp have been highlighted as Zacks Bull and Bear of the Day
11:30am, Friday, 17'th Jun 2022 Zacks Investment Research
Oxford Industries and Flagstar Bancorp have been highlighted as Zacks Bull and Bear of the Day.
FDA panel gives go-ahead for children under 5 to be vaccinated, but experts fret that not all parents will get on board
11:23am, Friday, 17'th Jun 2022 MarketWatch
A panel of advisers to the Food and Drug Administration on Wednesday gave its endorsement to both the Moderna and Pfizer vaccines for children below the age of five, the last group to be added to th
Everything you need to know about covid-19 vaccines for kids under 5
03:56pm, Thursday, 16'th Jun 2022 Quartz
Two vaccines are about to be available for children between six months and 4-5 years.
Why Pfizer, BioNTech, and Moderna Stocks Are Sinking Today
03:48pm, Thursday, 16'th Jun 2022 The Motley Fool
Blame it on the overall stock market sell-off.
Why Novavax Stock Buckled Today
03:23pm, Thursday, 16'th Jun 2022 The Motley Fool
Rising interest rates and successes by comeptitors make for a bad combination.
Here Are 31 Billion Reasons to Love Pfizer's Stock Right Now
03:15pm, Thursday, 16'th Jun 2022 The Motley Fool
This drugmaker's business looks healthy.
3 Things to Look for With Inflation-Fighting Stocks
02:00pm, Thursday, 16'th Jun 2022 The Motley Fool
There's more than one way to mitigate the impact of rising prices.
